← Evidence map

ArticleToxicology and applied pharmacology2012

Atrazine acts as an endocrine disrupter by inhibiting cAMP-specific phosphodiesterase-4.

Marek Kucka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

50 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23022511